...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trillium
7
Aug 23, 2021 01:03PM
5
Aug 25, 2021 11:20AM
7
Aug 25, 2021 10:23PM
6
Aug 26, 2021 09:32AM
4
Aug 26, 2021 11:11AM
5
Aug 26, 2021 11:25AM
3
Aug 26, 2021 12:55PM
3
Aug 26, 2021 02:45PM

Thanks kbc for straightening me out on expectations.

I would have thought that a cancer drug that can extend the length of effectiveness of numerous existing cancer therapies would have had some value.

I have no interest in a CVR at $1.

Cheers

Toinv

6
Aug 28, 2021 08:17AM
Share
New Message
Please login to post a reply